Skip to main content

FDA Approves Long-Awaited Cholesterol Drugs

Federal regulators have signed off on a new drug that lowers cholesterol, a development that could bring an important but costly new medical tool to fighting heart disease.

Republish
Lead image for this article

Federal regulators have signed off on a new drug that lowers cholesterol, a development that could bring an important but costly new medical tool to fighting heart disease. The drugs — which could benefit millions — are an alternative to the much-cheaper statins, the common cholesterol-lowering drug that might not be adequate for some. (Wall Street Journal) 

Texans need truth. Help us report it.

Independent Texas reporting needs your support. The Texas Tribune delivers fact-based journalism for Texans, by Texans — and our community of members, the readers who donate, make our work possible. Help us bring you and millions of others in-depth news and information. Will you support our nonprofit newsroom with a donation of any amount?

Yes, I'll donate today

Information about the authors

Learn about The Texas Tribune’s policies, including our partnership with The Trust Project to increase transparency in news.

Explore related story topics